Sun Pharmaceuticals
Ranbaxy follows Sun Pharma in demerging R&D business
By | 19 Oct 2007
US FDA approves Sun Pharmaceutical'' version of Novartis''s Trileptal tablets for US sales
By | 10 Oct 2007
Impressive results by Sun Pharma
By Our Corporate Bureau | 31 Oct 2005
Sun Pharma to buy manufacturing site in Hungary
By Our Corporate Bureau | 11 Aug 2005
Sun Pharma to issue $75 million FCCB
By Our Corporate Bureau | 06 Dec 2004
Sun Pharma launches $225 million FCCB
By Our Corporate Bureau | 19 Nov 2004
Sun Pharmaceuticals proposes share swap with Phlox Pharma
By Our Corporate Bureau | 03 Aug 2004
Sun Pharma plants get US regulatory clearance
By Our Corporate Bureau | 28 May 2004
Two Sun Pharma units gets USFDA approval
By Our Corporate Bureau | 27 May 2004
Sun Pharma increases holding in Caraco
By Our Corporate Bureau | 16 Mar 2004
Sun Pharma to increase holdings in Caraco to 60 per cent
By Our Corporate Bureau | 09 Feb 2004
Sun Pharma logs healthy growth
By Venkatachari Jagannathan | 03 Feb 2004
Sun Pharmaceuticals approves resolutions for split, buyback
By Our Corporate Bureau | 21 Dec 2002
Sun Pharma clocks 12% turnover, 14% PAT increase in Q2
By Our Corporate Bureau | 29 Oct 2002
DCI team clears Sun Pharma research facility
By Venkatachari Jagannathan | 18 Sep 2002
Sun Pharma sales, profit up; dividend at 50%
By Venkatachari Jagannathan | 01 Jun 2002
Sun Pharma meet on merger with MJ Pharma
By Venkatachari Jagannathan | 27 May 2002
Sun Pharma commissions Dadra plant
30 Mar 2002
Caraco gets FDA nod for a drug
By September 2001, the interest payout | 09 Jan 2002
Explosion at Sun Pharma lab
08 Jan 2002
Sildenafil citrate drug sales surge
By Praveen Chandran | 05 Dec 2001
Sun Pharma launches cure for smoking
By Venkatachari Jagannathan | 14 Aug 2001
Will the ‘Sun’ rise on Caraco Pharmaceuticals?
By Venkatachari Jagannathan | 10 Apr 2001
Sun Pharma announces 1:500 share swap for Pradeep Drugs
By The board of directors of Mumbai-based Sun Pharmac | 27 Feb 2001
Sun Pharma plans to take over Pradeep Drugs
By The Mumbai-based, Rs.476-crore turnover pharma maj | 16 Feb 2001
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation